DePuy Orthopaedics Newswire

DePuy Orthopaedics Newswire

Comprehensive Real-Time News Feed for DePuy Orthopaedics.

Results 1 - 20 of 305 in DePuy Orthopaedics

  1. New experimental HIV vaccine shows promiseRead the original story

    Yesterday | Nerve News

    A vaccine regimen that first primes the immune system and then boosts it to increase the response could ultimately prove to be the strategy for protecting against the global human immunodeficiency virus infection, new research suggests. The study showed that the investigational prime-boost vaccine regimen provided complete protection to non-human primates from becoming infected with simian immunodeficiency virus , a virus similar to HIV that infects the primates.

    Comment?

  2. Pfizer bought RTP drug firm Icagen for $56M, sells it for $500K plus 'earn outs'Read the original story w/Photo

    Thursday | Local Tech Wire

    Icagen, a Triangle-based drug firm that had pursued cures for such diseases as sickle cell anemia and epilepsy, is relaunching as a services company after the assets of the firm that were sold to Pfizer in 2011 are acquired by XPro Sciences. XPro is paying Pfizer $500,000 up front for the Icagen name, technology and employees plus "earn outs" for as much as $10.5 million.

    Comment?

  3. Drug, medical device makers major funders of research at Triad hospitalsRead the original story w/Photo

    Thursday | Business Journal

    ... to multiple sclerosis patients taking the drug Alemtuzumab. Another large payment - $100,000 - was from DePuy Orthopaedics, which makes artificial joints, for a study related to orthopedic trauma. "That's been a priority for us - to grow these ...

    Comment?

  4. One year later: the Acquia Certification ProgramRead the original story

    Wednesday Jul 1 | Planet RDF

    A little over a year ago we launched the Acquia Certification Program for Drupal . We ended up the first year with close to 1,000 exams taken, which exceeded our goal of 300-600.

    Comment?

  5. One Put, One Call Option To Know About for Johnson & JohnsonRead the original story w/Photo

    Monday Jun 29 | Forbes.com

    Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the October expiration for JNJ.

    Comment?

  6. A Chip That Mimics Human Organs Is the Design of the YearRead the original story w/Photo

    Tuesday Jun 23 | Wired

    Earlier this year, Paola Antonelli, the senior curator of design and architecture at the Museum of Modern Art, added an intriguing object to the museum's permanent collection. It was a clear plastic chip, no bigger than a thumb drive, and it could soon change the way scientists develop and test life-saving medicines.

    Comment?

  7. Mahama reasons like a stone age man - Chairman WontumiRead the original story w/Photo

    Tuesday Jun 23 | Ghanamma.com

    Had it not been for Parliaments' intervention, the Food and Drugs Authority would have continued with its decision to inject Ebola vaccines into volunteers from the Volta Region. Ghana is yet to record a case of Ebola; but under the leadership of President Mahama, the drugs made by Johnson & Johnson and Bavarian Nordic were to be tested on volunteers in Hohoe.

    Comment?

  8. Smartphone makes home workouts easierRead the original story w/Photo

    Monday Jun 22 | WTSP-TV Saint Petersburg

    Smartphone makes home workouts easier At home workouts are now easier than ever, thanks to your smart phone. Check out this story on wtsp.com: http://on.wtsp.com/1LqwBZ8 "It's so fast.

    Comment?

  9. A Historical Look At The 4 Stages Of Portfolio GrowthRead the original story w/Photo

    Monday Jun 22 | Seeking Alpha

    In a previous article I worked through the "4 stages of portfolio growth." Without having to go back and read the article, the idea was that an individual's portfolio growth could vary dramatically as compared to their underlying investments.

    Comment?

  10. Interesting September Stock Options for Johnson & JohnsonRead the original story w/Photo

    Monday Jun 22 | Forbes.com

    We work to find the most relevant and interesting articles about yield stocks to share with Forbes readers. The site is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.

    Comment?

  11. J&J in Class Action Lawsuit After Claims of Illegal FaxingBy: Mae KowalkeRead the original story w/Photo

    Monday Jun 22 | TMCnet

    Johnson & Johnson recently got the bad news: The class action lawsuit against one of its units for illegally faxing drug advertisements looks to be pressing ahead. The Johnson & Johnson arm, Janssen Pharmaceuticals Inc., has faced a class action lawsuit accusing it of sending unsolicited advertisements by fax for its antibiotic, Levaquin.

    Comment?

  12. One Million Moms: Tylenol Will 'Regret' Airing Gay-Inclusive AdRead the original story w/Photo

    Sunday Jun 21 | On Top Magazine

    Christian conservative group One Million Moms is urging its followers to take action against Tylenol over a gay-inclusive campaign. The campaign, #HowWeFamily, debuted earlier this month with a gay-inclusive ad, which features various couples, including a lesbian couple and a male couple with their baby.

    Comment?

  13. Lillian Grimmer, Adair County, KY,Read the original story

    Friday Jun 19 | Columbia Magazine

    Lillian Grimmer, Adair County, KY, She was a native of Adair County, KY, and will be laid to rest here. She was a resident of Barren County, KY, at the time of her death.

    Comment?

  14. Wyss Institute's organs-on-chips to be used in drug research at J&JRead the original story w/Photo

    Thursday Jun 18 | Business Journal

    Thumb-sized chips designed at Harvard's Wyss Institute to simulate different organs in the body will be used by the pharmaceutical arm of Johnson & Johnson in early testing of cancer and other drugs under a collaboration disclosed today.

    Comment?

  15. Employer of The Year: Plastek IndustriesRead the original story w/Photo

    Jan 12, 2015 | WICU12 Erie

    "We'll make billions and billions of individual components, and hundreds of millions of assemblies," Dennis Prischak says. "The bulk are still done in Erie."

    Comment?

  16. The 4 Stages Of Portfolio GrowthRead the original story w/Photo

    Wednesday Jun 17 | Seeking Alpha

    Collective investment returns, both historical and forward-looking, are presumed to be in a reasonably tight range over the long term. When the investment community thinks about typical growth rates, something in the 6% to 10% range usually appears reasonable over the long term.

    Comment?

  17. I've Added Johnson & Johnson To The IRA For BalanceRead the original story w/Photo

    Wednesday Jun 17 | Seeking Alpha

    I've been using AT&T as my cash cow but wanted to diversify away from it by adding Johnson & Johnson. The portfolio has returned 2.63% on the year so far against an S&P 500 which has returned 1.85%.

    Comment?

  18. 80 new jobs for CorkRead the original story w/Photo

    Wednesday Jun 17 | Business World

    DePuy Synthes Companies of Johnson & Johnson have officially opened a new 53.2 million 320,000 square foot state-of-the-art plant expansion. It is expected that this investment will bring an additional 80 new jobs to the estimated 800 positions already at the site in Cork, Ireland.

    Comment?

  19. Johnson & Johnson Heading for Another RallyRead the original story w/Photo

    Wednesday Jun 17 | TheStreet.com

    The stock began this week with a downside gap. It then drifted down to the $97 area before managing a slight bounce late in Monday's session.

    Comment?

  20. Johnson & Johnson Is Heading for Another RallyRead the original story w/Photo

    Wednesday Jun 17 | TheStreet.com

    The stock began this week with a downside gap. The stock then drifted down to the $97 area before managing a slight bounce late in Monday's session.

    Comment?